A PHASE IB/II STUDY TO EVALUATE SAFETY AND EFFICACY OF BEXMARILIMAB IN COMBINATION WITH DOXORUBICIN IN METASTATIC SOFT-TISSUE SARCOMA
Clinical trial NCT07460986 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07460986
- Sponsor
- MedSIR
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-07-01
- Primary completion
- 2028-07-01
- Enrollment
- 278
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.